Cargando…

An in vivo mouse model of primary dysmenorrhea

Primary dysmenorrhea (PD) is a common gynecological disorder. Hitherto, animal models which recapitulate clinical features of PD have not been fully established. We aimed to examine whether a pain model in mice could mimic the clinic features of PD. After pretreated with estradiol benzoate (1 mg/kg/...

Descripción completa

Detalles Bibliográficos
Autores principales: YANG, Lu, CAO, Zhengyu, YU, Boyang, CHAI, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Association for Laboratory Animal Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548002/
https://www.ncbi.nlm.nih.gov/pubmed/25912320
http://dx.doi.org/10.1538/expanim.14-0111
_version_ 1782387132313108480
author YANG, Lu
CAO, Zhengyu
YU, Boyang
CHAI, Chengzhi
author_facet YANG, Lu
CAO, Zhengyu
YU, Boyang
CHAI, Chengzhi
author_sort YANG, Lu
collection PubMed
description Primary dysmenorrhea (PD) is a common gynecological disorder. Hitherto, animal models which recapitulate clinical features of PD have not been fully established. We aimed to examine whether a pain model in mice could mimic the clinic features of PD. After pretreated with estradiol benzoate (1 mg/kg/day) intraperitoneally (i.p.) for 3 consecutive days, non-pregnant female Imprinting Control Region mice (6–8 weeks old) was injected with 0.4 U of oxytocin to induce the stretching or writhing response which was recorded for a time period of 30 min. During the writhing period, the uterine artery blood flow alterations were examined by Doppler ultrasound detection. After writhing test, the uterine morphological changes were observed by hematoxylin and eosin (H&E) staining histopathology. In addition, enzyme-linked immunosorbent assay kit was used to measure the levels of prostaglandins F(2α)/prostaglandins E(2) (PGF(2α)/PGE(2)) and TXB(2) (a metabolite of TXA(2))/6-keto-PGF(1α) (a metabolite of PGI(2)) in the uterine tissue homogenates and plasma, respectively. Western blot analyses were performed to determine the expressions of oxytocin receptor (OTR), beta2-adrenergic receptor (beta2-AR), and cyclooxygenase-2 (COX-2) in uterine, which are responsible for the uterine contraction. The writhing response only occurred in the estrogen pretreated female mice. The area of uterine myometrium significantly decreased along with the increased thickness in the oxytocin-induced estrogen pretreated mice model. The uterine artery blood flow velocity dropped, while the pulsatility index and resistance index slightly increased after the injection of oxytocin. The PGF(2α)/PGE(2) level significantly increased and the plasma TXB(2)/6-keto-PGF(1α) level significantly enhanced. Compared with the control group, the uterine histopathology demonstrated moderate to severe edema of endometrium lamina propria. In consistent with the uterine morphological changes, a significant reduction of beta2-AR and a significant increase of OTR and COX-2 in the uterine tissue were observed. The writhing response was caused by the abnormal contraction of uterus. The uterine spasm and ischemia changes of oxytocin-induced estrogen pretreated female mice model were similar to the pathology of human PD. We reported an in vivo mice model, which can be used to study PD and for clinical therapeutic evaluations.
format Online
Article
Text
id pubmed-4548002
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Japanese Association for Laboratory Animal Science
record_format MEDLINE/PubMed
spelling pubmed-45480022015-08-26 An in vivo mouse model of primary dysmenorrhea YANG, Lu CAO, Zhengyu YU, Boyang CHAI, Chengzhi Exp Anim Original Primary dysmenorrhea (PD) is a common gynecological disorder. Hitherto, animal models which recapitulate clinical features of PD have not been fully established. We aimed to examine whether a pain model in mice could mimic the clinic features of PD. After pretreated with estradiol benzoate (1 mg/kg/day) intraperitoneally (i.p.) for 3 consecutive days, non-pregnant female Imprinting Control Region mice (6–8 weeks old) was injected with 0.4 U of oxytocin to induce the stretching or writhing response which was recorded for a time period of 30 min. During the writhing period, the uterine artery blood flow alterations were examined by Doppler ultrasound detection. After writhing test, the uterine morphological changes were observed by hematoxylin and eosin (H&E) staining histopathology. In addition, enzyme-linked immunosorbent assay kit was used to measure the levels of prostaglandins F(2α)/prostaglandins E(2) (PGF(2α)/PGE(2)) and TXB(2) (a metabolite of TXA(2))/6-keto-PGF(1α) (a metabolite of PGI(2)) in the uterine tissue homogenates and plasma, respectively. Western blot analyses were performed to determine the expressions of oxytocin receptor (OTR), beta2-adrenergic receptor (beta2-AR), and cyclooxygenase-2 (COX-2) in uterine, which are responsible for the uterine contraction. The writhing response only occurred in the estrogen pretreated female mice. The area of uterine myometrium significantly decreased along with the increased thickness in the oxytocin-induced estrogen pretreated mice model. The uterine artery blood flow velocity dropped, while the pulsatility index and resistance index slightly increased after the injection of oxytocin. The PGF(2α)/PGE(2) level significantly increased and the plasma TXB(2)/6-keto-PGF(1α) level significantly enhanced. Compared with the control group, the uterine histopathology demonstrated moderate to severe edema of endometrium lamina propria. In consistent with the uterine morphological changes, a significant reduction of beta2-AR and a significant increase of OTR and COX-2 in the uterine tissue were observed. The writhing response was caused by the abnormal contraction of uterus. The uterine spasm and ischemia changes of oxytocin-induced estrogen pretreated female mice model were similar to the pathology of human PD. We reported an in vivo mice model, which can be used to study PD and for clinical therapeutic evaluations. Japanese Association for Laboratory Animal Science 2015-04-24 2015 /pmc/articles/PMC4548002/ /pubmed/25912320 http://dx.doi.org/10.1538/expanim.14-0111 Text en ©2015 Japanese Association for Laboratory Animal Science http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.
spellingShingle Original
YANG, Lu
CAO, Zhengyu
YU, Boyang
CHAI, Chengzhi
An in vivo mouse model of primary dysmenorrhea
title An in vivo mouse model of primary dysmenorrhea
title_full An in vivo mouse model of primary dysmenorrhea
title_fullStr An in vivo mouse model of primary dysmenorrhea
title_full_unstemmed An in vivo mouse model of primary dysmenorrhea
title_short An in vivo mouse model of primary dysmenorrhea
title_sort in vivo mouse model of primary dysmenorrhea
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548002/
https://www.ncbi.nlm.nih.gov/pubmed/25912320
http://dx.doi.org/10.1538/expanim.14-0111
work_keys_str_mv AT yanglu aninvivomousemodelofprimarydysmenorrhea
AT caozhengyu aninvivomousemodelofprimarydysmenorrhea
AT yuboyang aninvivomousemodelofprimarydysmenorrhea
AT chaichengzhi aninvivomousemodelofprimarydysmenorrhea
AT yanglu invivomousemodelofprimarydysmenorrhea
AT caozhengyu invivomousemodelofprimarydysmenorrhea
AT yuboyang invivomousemodelofprimarydysmenorrhea
AT chaichengzhi invivomousemodelofprimarydysmenorrhea